Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022668610> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2022668610 endingPage "115" @default.
- W2022668610 startingPage "110" @default.
- W2022668610 abstract "Introduction: In developing countries the standard methods used to monitor HIV disease progression and therapy response are clinical assessment, CD4+ T lymphocyte count measurement, and plasma viral load (PVL) quantification. These tests require expensive equipment and skilled technicians, so monitoring HIV in resource-limited countries remains challenging as few laboratories can offer these tests free of cost. Methodology: Newly diagnosed HIV seropositive subjects (n = 130) were categorized into three study groups: CD4 counts <200 cells/µl (group A, 43 subjects); 200-500 cells/µl (group B, 44 subjects); and >500 cells/µl (group C, 43 subjects). At recruitment, PVL estimation was performed for group A subjects only, who were then initiated on highly active antiretroviral therapy (HAART) and were followed up after six months for evaluation of response to HAART by measuring the CD4 counts and PVL. Groups B and C were followed up after six months to monitor disease progression by measuring only CD4 counts. Results: Among group A subjects, a rise in the median CD4 counts after six months of HAART was observed. At baseline, PVL ranged from 2636 to >750,000 copies/ml with a median PVL at baseline of 165,000 copies/ml. At follow-up, 90% of the study subjects had undetectable levels of viraemia. Among group B and C subjects, a fall in the CD4 counts at follow-up was observed. Conclusions: CD4 count is a powerful tool to determine response to antiretroviral therapy (ART) and monitor disease progression in HIV/AIDS. PVL is important to assess response to ART, especially in immunovirologic discordant responses." @default.
- W2022668610 created "2016-06-24" @default.
- W2022668610 creator A5018522645 @default.
- W2022668610 creator A5021097621 @default.
- W2022668610 creator A5027156415 @default.
- W2022668610 creator A5042832587 @default.
- W2022668610 creator A5077605630 @default.
- W2022668610 creator A5078872874 @default.
- W2022668610 creator A5086928236 @default.
- W2022668610 date "2013-02-15" @default.
- W2022668610 modified "2023-09-27" @default.
- W2022668610 title "Disease progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India" @default.
- W2022668610 cites W1836760160 @default.
- W2022668610 cites W1972350208 @default.
- W2022668610 cites W1976632658 @default.
- W2022668610 cites W1977101066 @default.
- W2022668610 cites W2014801327 @default.
- W2022668610 cites W2018341864 @default.
- W2022668610 cites W2029383937 @default.
- W2022668610 cites W2043192633 @default.
- W2022668610 cites W2116771659 @default.
- W2022668610 cites W2121118810 @default.
- W2022668610 cites W2148137618 @default.
- W2022668610 cites W2148391396 @default.
- W2022668610 cites W2157378287 @default.
- W2022668610 cites W2160538807 @default.
- W2022668610 cites W2315151343 @default.
- W2022668610 cites W2333915181 @default.
- W2022668610 cites W2399671954 @default.
- W2022668610 cites W2897034676 @default.
- W2022668610 doi "https://doi.org/10.3855/jidc.2875" @default.
- W2022668610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23416656" @default.
- W2022668610 hasPublicationYear "2013" @default.
- W2022668610 type Work @default.
- W2022668610 sameAs 2022668610 @default.
- W2022668610 citedByCount "2" @default.
- W2022668610 countsByYear W20226686102015 @default.
- W2022668610 countsByYear W20226686102019 @default.
- W2022668610 crossrefType "journal-article" @default.
- W2022668610 hasAuthorship W2022668610A5018522645 @default.
- W2022668610 hasAuthorship W2022668610A5021097621 @default.
- W2022668610 hasAuthorship W2022668610A5027156415 @default.
- W2022668610 hasAuthorship W2022668610A5042832587 @default.
- W2022668610 hasAuthorship W2022668610A5077605630 @default.
- W2022668610 hasAuthorship W2022668610A5078872874 @default.
- W2022668610 hasAuthorship W2022668610A5086928236 @default.
- W2022668610 hasBestOaLocation W20226686101 @default.
- W2022668610 hasConcept C126322002 @default.
- W2022668610 hasConcept C142462285 @default.
- W2022668610 hasConcept C203014093 @default.
- W2022668610 hasConcept C2777761686 @default.
- W2022668610 hasConcept C2779134260 @default.
- W2022668610 hasConcept C2993143319 @default.
- W2022668610 hasConcept C3013748606 @default.
- W2022668610 hasConcept C71924100 @default.
- W2022668610 hasConcept C90924648 @default.
- W2022668610 hasConceptScore W2022668610C126322002 @default.
- W2022668610 hasConceptScore W2022668610C142462285 @default.
- W2022668610 hasConceptScore W2022668610C203014093 @default.
- W2022668610 hasConceptScore W2022668610C2777761686 @default.
- W2022668610 hasConceptScore W2022668610C2779134260 @default.
- W2022668610 hasConceptScore W2022668610C2993143319 @default.
- W2022668610 hasConceptScore W2022668610C3013748606 @default.
- W2022668610 hasConceptScore W2022668610C71924100 @default.
- W2022668610 hasConceptScore W2022668610C90924648 @default.
- W2022668610 hasIssue "02" @default.
- W2022668610 hasLocation W20226686101 @default.
- W2022668610 hasLocation W20226686102 @default.
- W2022668610 hasOpenAccess W2022668610 @default.
- W2022668610 hasPrimaryLocation W20226686101 @default.
- W2022668610 hasRelatedWork W2032562761 @default.
- W2022668610 hasRelatedWork W2055888974 @default.
- W2022668610 hasRelatedWork W2071428655 @default.
- W2022668610 hasRelatedWork W2321454061 @default.
- W2022668610 hasRelatedWork W2332504999 @default.
- W2022668610 hasRelatedWork W2527791583 @default.
- W2022668610 hasRelatedWork W2912123654 @default.
- W2022668610 hasRelatedWork W2987747606 @default.
- W2022668610 hasRelatedWork W4308810341 @default.
- W2022668610 hasRelatedWork W4318822302 @default.
- W2022668610 hasVolume "7" @default.
- W2022668610 isParatext "false" @default.
- W2022668610 isRetracted "false" @default.
- W2022668610 magId "2022668610" @default.
- W2022668610 workType "article" @default.